title: What is the best medical treatment for benign prostate hyperplasia?
authors.affiliation: Toronto Hospital. michael.evans@utoronto.ca
authors.forename: M F
authors.initials: MF
authors.lastname: Evans
authors.forename: J
authors.initials: J
authors.lastname: Frank
mesh_terms: D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D004359:Drug Therapy, Combination; D005194:Family Practice; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011224:Prazosin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D018120:Finasteride; C041226:Terazosin; D011224:Prazosin